BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 19, 2019
View Archived Issues
CXCL10 arises as a potential therapeutic target for treating motor neuron disease
Read More
Sangamo Therapeutics presents preliminary data from phase I/II study of ST-400
Read More
MEDS-433 demonstrates promising antileukemic activity and limited toxicity in vivo
Read More
First data presented for XmAb-13676 in refractory/relapsed NHL and CLL
Read More
ALDH2 and Alzheimer's
Read More
Getting, and keeping, antitumor T cells energized
Read More
First-in-human findings presented for CC-93269
Read More
First transgenic animal model for IRF4-induced lymphoid malignancy
Read More
Phase I study of Metablok achieves primary endpoints
Read More
Interim data presented from phase I/II study of RGX-121
Read More
Boehringer Ingelheim announces discontinuation of development of BI-1467335 for NASH
Read More
First patients dosed in phase I clinical program of CTI-1601 for treatment of Friedreich's ataxia
Read More
First patient dosed in MAESTRO-NAFLD-1 phase III study of resmetirom
Read More
Initiation of first-in-human study of ANLE-138b
Read More
Medivir initiates phase II study of remetinostat in patients with squamous cell carcinoma
Read More
Jiangsu Chia Tai Tianqing Pharmaceutical Group, Medshine Discovery patent anti-HBV agents
Read More
e-Therapeutics identifies new IDO-1 and/or TDO inhibitors
Read More
Corbus Pharmaceuticals describes new cannabinoid CB2 receptor agonists
Read More
New SLC10A2/SLC10A1 inhibitors identified at Albireo
Read More
Medshine Discovery discloses ACC1/ACC2 inhibitors
Read More
New autoinflammatory disease linked to RIPK1 gene variants
Read More
European Commission approves Rinvoq for rheumatoid arthritis
Read More
Inventiva reports phase IIa results on odiparcil for MPS VI
Read More
NicOx reports data from phase II study of NCX-4251 for blepharitis
Read More
Kadcyla approved in E.U. for adjuvant treatment of HER2-positive early breast cancer
Read More
Rezolute reports phase I results for ultra long-acting basal insulin AB-101
Read More
FDA grants accelerated approval to Padcev for urothelial cancer
Read More